Sera Prognostics, Inc. Class A Common Stock
SERASera Prognostics, Inc. Class A (SERA) is a biotechnology company focused on developing maternal-fetal health diagnostics. The firm specializes in creating tests aimed at predicting the risk of preterm birth and other pregnancy complications, leveraging proteomic and biomarker analysis to improve maternal and neonatal outcomes.
Company News
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
Brookdale's (BKD) weighted average occupancy for the second quarter-to-date rises 160 bps year over year to 78%.
Select Medical (SEM) will continue to gain from rising admissions within the Critical Illness Recovery Hospital and Rehabilitation Hospital segments.
UnitedHealth's (UNH) strong financial position supports its shareholder value boosting efforts.
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
